Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide vs Metformin Vascular Effects in Pre-Diabetes
NCT00546728Phase 4Completed
- Sponsor
- St. Paul Heart Clinic
- Start
- Oct 2007
- Primary completion
- Jul 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in impaired glucose tolerance (IGT), sponsored by St. Paul Heart Clinic. Started Oct 2007; status: completed.
02
Drugs
exenatide
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00546728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546728.